cutaquig
Showing 1 - 2 of 2
Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety
Recruiting
- Primary Immunodeficiency Diseases (PID)
- Cutaquig
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
Aug 8, 2023
Primary Immune Deficiency Disorder Trial in United States (CUTAQUIG)
Completed
- Primary Immune Deficiency Disorder
- CUTAQUIG
-
Scottsdale, Arizona
- +17 more
Jan 10, 2022